Bezlotoxumab

Category: Immune System



Bezlotoxumab Overview

Bezlotoxumab (trade name Zinplava) is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficile infections.[1] This drug, along with actoxumab, was developed through Phase II efficacy trials by a partnership between Medarex Inc and MassBiologics of the University of Massachusetts Medical School.[2] The project was then licensed to Merck Sharp & Dohme Corp for further development and commercialization.[3] ...

Read more Bezlotoxumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bezlotoxumab

Recent Bezlotoxumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Bezlotoxumab
  • Injection: 1000ml/40ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Bezlotoxumab or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA